The HEAL-IST IDE Trial is underway to evaluate the safety and effectiveness of a new treatment called a hybrid sinus node sparing ablation in patients with symptomatic Inappropriate Sinus Tachycardia (IST).
To learn more about the HEAL-IST Trial and hybrid sinus node sparing procedure, visit: www.heal-ist.com.
<a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=InnapropriateSinusTachy…; target='_blank'>#InnapropriateSinusTachycardia</a>